Hypohidrotic ectodermal dysplasia with immune deficiency

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Hypohidrotic ectodermal dysplasia with immune deficiency | |
|---|---|
| Synonyms | HED-ID, EDA-ID |
| Pronounce | N/A |
| Specialty | Medical genetics, Immunology |
| Symptoms | Hypohidrosis, Ectodermal dysplasia, Immune deficiency |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the NEMO gene |
| Risks | Infections, Hyperthermia |
| Diagnosis | Genetic testing, Clinical evaluation |
| Differential diagnosis | Other ectodermal dysplasias, Primary immunodeficiencies |
| Prevention | N/A |
| Treatment | Symptomatic treatment, Immunoglobulin replacement therapy |
| Medication | N/A |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | N/A |
Hypohidrotic Ectodermal Dysplasia with Immune Deficiency (HED-ID) is a rare genetic disorder that affects several structures including the skin, hair, teeth, and immune system. This condition is part of a group of disorders known as ectodermal dysplasias, which primarily affect the development of the ectodermal tissues. HED-ID is particularly notable for its impact not only on ectodermal structures but also on the immune system, leading to a predisposition to various infections.
Symptoms and Characteristics[edit]
The hallmark features of Hypohidrotic Ectodermal Dysplasia include a reduced ability to sweat (hypohidrosis), sparse hair (hypotrichosis), and missing or malformed teeth (anodontia or hypodontia). These symptoms are due to the abnormal development of ectodermal tissues. In addition to these ectodermal symptoms, individuals with HED-ID also experience a range of immune system deficiencies, which can lead to an increased susceptibility to bacterial, viral, and fungal infections. The immune deficiency aspect of this disorder is what distinguishes HED-ID from other forms of ectodermal dysplasia.
Genetics[edit]
Hypohidrotic Ectodermal Dysplasia with Immune Deficiency is most commonly associated with mutations in the IKBKG gene, also known as NEMO (NF-kappaB essential modulator). This gene plays a crucial role in the NF-kappaB signaling pathway, which is important for immune system function and the development of ectodermal tissues. The disorder is inherited in an X-linked recessive pattern, meaning that it predominantly affects males, while females who carry one copy of the mutation may show milder symptoms or be asymptomatic.
Diagnosis[edit]
Diagnosis of HED-ID involves a combination of clinical evaluation and genetic testing. Clinical evaluation focuses on identifying characteristic symptoms of ectodermal dysplasia and assessing immune function. Genetic testing can confirm a diagnosis by identifying mutations in the IKBKG gene. Early diagnosis is crucial for managing symptoms and preventing severe infections.
Treatment[edit]
There is no cure for Hypohidrotic Ectodermal Dysplasia with Immune Deficiency, and treatment focuses on managing symptoms and preventing infections. Management strategies may include:
- Use of artificial tears and saliva substitutes to alleviate dryness of the eyes and mouth.
- Dental prosthetics to address missing or malformed teeth.
- Antibiotic prophylaxis or prompt treatment of infections.
- Immunoglobulin therapy may be recommended for some individuals to boost the immune system.
Preventive measures, such as avoiding overheating due to the reduced ability to sweat, are also important.
Prognosis[edit]
The prognosis for individuals with HED-ID varies depending on the severity of the symptoms and the effectiveness of the management strategies. With appropriate care, most individuals can lead active lives, although they may have an increased risk of infections throughout life.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
